Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T17:13:13.811Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:13:13.811Z.

Quote observation: 2026-10-06T17:10:21.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 5,916,151,500
TTM operating cash flow · period ending 2026-06-30: -264,182,000

FMP input reference: f23401f377ae0c42cb4058dfce1620411e9c781823cb8ffdb9eedba1333334c1

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

IOVA Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

PRICE/OCF RATIO AVG TTM

N/A

PRICE/OCF RATIO AVG 3Y

N/A

PRICE/OCF RATIO AVG 5Y

N/A

PRICE/OCF RATIO AVG 10Y

N/A

PRICE/OCF RATIO AVG 15Y

N/A

PRICE/OCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

IOVA Competitors' Price/OCF Ratio

IOVA

Iovance Biotherapeutics, Inc.

Current

Market Cap

$5.92B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LGND

Ligand Pharmaceuticals Incorporated

vs IOVA

Market Cap

$5.94B

Price/OCF Ratio

45.15

TTM Avg

80.09

3Y Avg

48.34

5Y Avg

34.61

KOD

Kodiak Sciences Inc.

vs IOVA

Market Cap

$5.82B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRAL

GRAIL Inc.

vs IOVA

Market Cap

$6.02B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KNSA

Kiniksa Pharmaceuticals International, plc

vs IOVA

Market Cap

$5.75B

Price/OCF Ratio

31.02

TTM Avg

31.51

3Y Avg

57.31

5Y Avg

58.06

CGON

CG Oncology Inc.

vs IOVA

Market Cap

$5.66B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RYTM

Rhythm Pharmaceuticals, Inc.

vs IOVA

Market Cap

$6.20B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RDNT

RadNet, Inc.

vs IOVA

Market Cap

$5.53B

Price/OCF Ratio

17.45

TTM Avg

17.73

3Y Avg

17.23

5Y Avg

13.87

MMED

MiniMed Group, Inc. Common Stock

vs IOVA

Market Cap

$5.52B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMRX

Amneal Pharmaceuticals, Inc.

vs IOVA

Market Cap

$6.49B

Price/OCF Ratio

32.32

TTM Avg

16.27

3Y Avg

10.55

5Y Avg

7.93

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Iovance Biotherapeutics, Inc. (IOVA)	$5.92B	N/A	N/A	N/A	N/A
Ligand Pharmaceuticals Incorporated (LGND)vs ›	$5.94B	45.15	80.09	48.34	34.61
Kodiak Sciences Inc. (KOD)vs ›	$5.82B	N/A	N/A	N/A	N/A
GRAIL Inc. (GRAL)vs ›	$6.02B	N/A	N/A	N/A	N/A
Kiniksa Pharmaceuticals International, plc (KNSA)vs ›	$5.75B	31.02	31.51	57.31	58.06
CG Oncology Inc. (CGON)vs ›	$5.66B	N/A	N/A	N/A	N/A
Rhythm Pharmaceuticals, Inc. (RYTM)vs ›	$6.20B	N/A	N/A	N/A	N/A
RadNet, Inc. (RDNT)vs ›	$5.53B	17.45	17.73	17.23	13.87
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.52B	N/A	N/A	N/A	N/A
Amneal Pharmaceuticals, Inc. (AMRX)vs ›	$6.49B	32.32	16.27	10.55	7.93

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IOVA Price/OCF Ratio History

DATE	PRICE/OCF RATIO
2014-03-27	1.19
2014-03-26	1.21
2014-03-25	1.22
2014-03-24	1.18
2014-03-21	1.28
2014-03-20	1.33
2014-03-19	1.25
2014-03-18	1.21
2014-03-17	1.19
2014-03-14	1.13
2014-03-13	1.18
2014-03-12	1.24
2014-03-11	1.25
2014-03-10	1.34
2014-03-07	1.30
2014-03-06	1.19
2014-03-05	1.23
2014-03-04	1.02
2014-03-03	0.91
2014-02-28	0.82
2014-02-27	0.88
2014-02-26	0.88
2014-02-25	0.89
2014-02-24	0.89
2014-02-21	0.84
2014-02-20	0.81
2014-02-19	0.78
2014-02-18	0.80
2014-02-14	0.87
2014-02-13	0.96
2014-02-12	0.90
2014-02-11	0.84
2014-02-10	0.78
2014-02-07	0.73
2014-02-06	0.74
2014-02-05	0.74
2014-02-04	0.75
2014-02-03	0.81
2014-01-31	0.74
2014-01-30	0.98
2014-01-29	0.97
2014-01-28	0.89
2014-01-27	0.86
2014-01-24	0.85
2014-01-23	0.85
2014-01-22	0.97
2014-01-21	1.10
2014-01-17	1.16
2014-01-16	1.20
2014-01-15	1.32
2014-01-14	1.27
2014-01-13	1.25
2014-01-10	1.19
2014-01-09	1.20
2014-01-08	1.27
2014-01-07	1.42
2014-01-06	1.43
2014-01-03	1.41
2014-01-02	1.46
2013-12-31	1.57
2013-12-30	1.64
2013-12-27	1.67
2013-12-26	1.45
2013-12-24	1.42
2013-12-23	1.42
2013-12-20	1.34
2013-12-19	1.42
2013-12-18	1.46
2013-12-17	1.42
2013-12-16	1.62
2013-12-13	1.42
2013-12-12	1.22
2013-12-11	1.28
2013-12-10	1.41
2013-12-09	1.58
2013-12-06	1.64
2013-12-05	1.55
2013-12-04	1.39
2013-12-03	1.31
2013-12-02	1.10
2013-11-29	1.26
2013-11-27	1.26
2013-11-26	1.10
2013-11-25	0.81
2013-11-22	0.75
2013-11-21	0.75
2013-11-20	0.78
2013-11-19	0.75
2013-11-18	1.00
2013-11-15	0.80
2013-11-14	0.66
2013-11-13	0.57
2013-11-12	0.55
2013-11-11	0.54
2013-11-08	0.54
2013-11-07	0.53
2013-11-06	0.53
2013-11-05	0.57
2013-11-04	0.61
2013-11-01	0.66
2013-10-31	0.72
2013-10-30	0.83
2013-10-29	0.81
2013-10-28	0.81
2013-10-25	0.82
2013-10-24	0.84
2013-10-23	0.84
2013-10-22	1.05
2013-10-21	1.02
2013-10-18	1.08
2013-10-17	1.11
2013-10-16	1.11
2013-10-15	1.11
2013-10-14	1.11
2013-10-11	1.30
2013-10-10	1.44
2013-10-09	1.69
2013-10-08	1.77
2013-10-07	1.86
2013-10-04	2.04
2013-10-03	1.76
2013-10-02	1.67
2013-10-01	1.21
2013-09-30	1.22
2013-09-27	0.94
2013-09-26	0.74
2013-09-25	0.74
2013-09-24	0.93

Price/OCF Ratio: N/A

IOVA Price/OCF Ratio Chart

IOVA Price/OCF Ratio Metrics

IOVA Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

IOVA Price/OCF Ratio History

Related Metrics